Literature DB >> 35514160

Corrigendum.

.   

Abstract

Entities:  

Year:  2022        PMID： 35514160      PMCID： PMC9073194          DOI： 10.1002/prp2.948

Source DB:  PubMed          Journal:  Pharmacol Res Perspect        ISSN： 2052-1707


× No keyword cloud information.
In Li et al. (2022), the below sentence have been included in the acknowledgment section: “We deeply appreciated the kindly gift of all the myricetin derivatives from Professor Wei Xue of Guizhou University.” The updated acknowledgment section is given below:
  1 in total

1.  Anticancer effects of myricetin derivatives in non-small cell lung cancer in vitro and in vivo.

Authors:  Mengmeng Li; Genlan Zha; Rujun Chen; Xin Chen; Qian Sun; Hao Jiang
Journal:  Pharmacol Res Perspect       Date:  2022-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.